AU1195497A - Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic - Google Patents

Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic

Info

Publication number
AU1195497A
AU1195497A AU11954/97A AU1195497A AU1195497A AU 1195497 A AU1195497 A AU 1195497A AU 11954/97 A AU11954/97 A AU 11954/97A AU 1195497 A AU1195497 A AU 1195497A AU 1195497 A AU1195497 A AU 1195497A
Authority
AU
Australia
Prior art keywords
alpha
pct
piperidyl
ester
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11954/97A
Inventor
Reinhard Laven
Eckhart Pein
Helmut Ritter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1195497A publication Critical patent/AU1195497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

PCT No. PCT/EP96/05627 Sec. 371 Date Oct. 27, 1997 Sec. 102(e) Date Oct. 27, 1997 PCT Filed Dec. 14, 1996 PCT Pub. No. WO97/22343 PCT Pub. Date Jun. 26, 1997The use of alpha , alpha -diphenylacetic acid-4-(N-methyl-piperidyl) ester for the treatment of painful muscular cramp conditions in the region of the abdominal cavity or for the production of drugs for the treatment of painful muscular cramp conditions in the region of the abdominal cavity.
AU11954/97A 1995-12-20 1996-12-14 Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic Abandoned AU1195497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19547621 1995-12-20
DE19547621 1995-12-20
PCT/EP1996/005627 WO1997022343A1 (en) 1995-12-20 1996-12-14 USE OF α,α-DIPHENYLACETIC ACID-4-(N-METHYL-PIPERIDYL)ESTER AS ANTI-SPASMODIC

Publications (1)

Publication Number Publication Date
AU1195497A true AU1195497A (en) 1997-07-14

Family

ID=7780682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11954/97A Abandoned AU1195497A (en) 1995-12-20 1996-12-14 Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic

Country Status (11)

Country Link
US (1) US5897875A (en)
EP (1) EP0868181B1 (en)
JP (1) JP2000502094A (en)
AT (1) ATE193445T1 (en)
AU (1) AU1195497A (en)
DE (2) DE19681129D2 (en)
DK (1) DK0868181T3 (en)
ES (1) ES2148828T3 (en)
GR (1) GR3033680T3 (en)
PT (1) PT868181E (en)
WO (1) WO1997022343A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678780A (en) * 1985-02-20 1987-07-07 United Pharmaceuticals, Inc. Anti-spasmodic agents having a ring in the main chain
IT1216461B (en) * 1988-02-26 1990-03-08 Milano DERIVATIVES OF 1_ARIL SOLFONIL2_PIRROLIDINONE THEIR PROCESSES OF PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS.
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them
US5153205A (en) * 1990-10-01 1992-10-06 Merck & Co., Inc. Method to reduce introacular pressure without causing miosis
DE4205843C2 (en) * 1992-02-26 1994-03-24 Schaper & Bruemmer Gmbh Use of alpha, alpha-diphenylacetic acid 4- (N-methyl-piperidyl) ester to influence urinary bladder tone

Also Published As

Publication number Publication date
EP0868181A1 (en) 1998-10-07
DE59605367D1 (en) 2000-07-06
JP2000502094A (en) 2000-02-22
ES2148828T3 (en) 2000-10-16
ATE193445T1 (en) 2000-06-15
US5897875A (en) 1999-04-27
EP0868181B1 (en) 2000-05-31
PT868181E (en) 2000-09-29
DK0868181T3 (en) 2000-09-11
GR3033680T3 (en) 2000-10-31
DE19681129D2 (en) 1999-07-01
WO1997022343A1 (en) 1997-06-26

Similar Documents

Publication Publication Date Title
DE59410052D1 (en) USE OF NONA AND DECAPEPTIDES FOR THE PRODUCTION OF A MEDICINAL AGAINST AIDS
AU684059B2 (en) Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes
IL111077A0 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
ZA966163B (en) Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives.
ATE235901T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-(2,2,2-TRIMETHYLHYDRAZINIUM)PROPRIONATE AND GAMMA-BUTYROBETAIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
MX9707642A (en) Pharmaceutical agents for the treatment of alzheimer's disease.
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
AU1195497A (en) Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic
HK1050203A1 (en) Novel fusidic acid derivatives.
ZA965749B (en) Use of allylamines.
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU675281B2 (en) Application of riluzole as a radiorestorer
MX9709684A (en) Use of vitamin d4 derivatives for treating skin disorders.
PL322847A1 (en) Condensed b-carbolins